Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom
Condition(s):Non-Small Cell Lung Cancer NSCLCLast Updated:October 2, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Non-Small Cell Lung Cancer NSCLCLast Updated:October 2, 2023Completed
Condition(s):Stage III Non-small Cell Lung Cancer; UnresectableLast Updated:December 12, 2023Completed
Condition(s):Non-small-cell Lung Cancer PatientsLast Updated:October 5, 2022Recruiting
Condition(s):Nonsmall Cell Lung Cancer Stage III; Unresectable Non-Small Cell Lung CarcinomaLast Updated:October 30, 2023Recruiting
Condition(s):Non-Small-Cell Lung CarcinomaLast Updated:March 13, 2008Unknown status
Condition(s):Stage III Non-Small Cell Lung CancerLast Updated:July 13, 2009Unknown status
Condition(s):Non-small Cell Lung CancerLast Updated:January 16, 2024Terminated
Condition(s):Non Small Cell Lung CancerLast Updated:October 31, 2018Completed
Condition(s):Non Small Cell Lung CancerLast Updated:May 6, 2021Active, not recruiting
Condition(s):Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; Large Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer; Squamous Cell Lung Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung CancerLast Updated:November 23, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.